Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2014 Earnings

8MayConfirmed

Q3 2013

Q4 2013

Q1 2014

Q2 2014

-1.31

-1.09

-0.88

-0.66

Details

Expected EPS

-1.3056699999999999

Actual EPS

-0.8630700000000001

Surprise EPS

0.44

Surprise Percent

+33.9%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -0.8630700000000001 per share for Q2 2014.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.